SOCS3 Transactivation by PPARγ Prevents IL-17-Driven Cancer Growth.
Data(s) |
2013
|
---|---|
Resumo |
Activation of the transcription factor PPARγ by the n-3 fatty acid docosahexaenoic acid (DHA) is implicated in controlling proinflammatory cytokine secretion, but the intracellular signaling pathways engaged by PPARγ are incompletely characterized. Here, we identify the adapter-encoding gene SOCS3 as a critical transcriptional target of PPARγ. SOCS3 promoter binding and gene transactivation by PPARγ was associated with a repression in differentiation of proinflammatory T-helper (TH)17 cells. Accordingly, TH17 cells induced in vitro displayed increased SOCS3 expression and diminished capacity to produce interleukin (IL)-17 following activation of PPARγ by DHA. Furthermore, naïve CD4 T cells derived from mice fed a DHA-enriched diet displayed less capability to differentiate into TH17 cells. In two different mouse models of cancer, DHA prevented tumor outgrowth and angiogenesis in an IL-17-dependent manner. Altogether, our results uncover a novel molecular pathway by which PPARγ-induced SOCS3 expression prevents IL-17-mediated cancer growth. Cancer Res; 73(12); 3578-90. ©2013 AACR. |
Identificador |
http://serval.unil.ch/?id=serval:BIB_8768846D2B6D isbn:1538-7445 (Electronic) doi:10.1158/0008-5472.CAN-12-4018 pmid:23619236 isiid:000320380300011 |
Idioma(s) |
en |
Fonte |
Cancer Research, vol. 73, no. 12, pp. 3578-3590 |
Tipo |
info:eu-repo/semantics/article article |